ArticleCancer gene therapy2020

Immunostimulatory oncolytic virotherapy for multiple myeloma targeting 4-1BB and/or CD40.

Jessica Wenthe et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.